Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of GBP 112.61 billion. The enterprise value is 153.48 billion.

Market Cap	112.61B
Enterprise Value	153.48B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Feb 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.16M

Valuation Ratios

The trailing PE ratio is 35.68.

PE Ratio	35.68
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.53, with an EV/FCF ratio of 32.74.

EV / Earnings	48.63
EV / Sales	5.93
EV / EBITDA	15.53
EV / EBIT	28.91
EV / FCF	32.74

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 8.02.

Current Ratio	1.32
Quick Ratio	0.80
Debt / Equity	8.02
Debt / EBITDA	4.86
Debt / FCF	9.61
Interest Coverage	2.07

Financial Efficiency

Return on equity (ROE) is 55.72% and return on invested capital (ROIC) is 6.13%.

Return on Equity (ROE)	55.72%
Return on Assets (ROA)	4.60%
Return on Capital (ROIC)	6.13%
Revenue Per Employee	909,124
Profits Per Employee	118,202
Employee Count	26,700
Asset Turnover	0.36
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.48%
50-Day Moving Average	297.72
200-Day Moving Average	306.00
Relative Strength Index (RSI)	34.54
Average Volume (20 Days)	16,429

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.46

Income Statement

In the last 12 months, Amgen had revenue of GBP 24.27 billion and earned 3.16 billion in profits. Earnings per share was 5.84.

Revenue	24.27B
Gross Profit	14.71B
Operating Income	4.98B
Pretax Income	3.49B
Net Income	3.16B
EBITDA	9.14B
EBIT	4.98B
Earnings Per Share (EPS)	5.84

Full Income Statement

Balance Sheet

The company has 6.72 billion in cash and 45.06 billion in debt, giving a net cash position of -38.34 billion.

Cash & Cash Equivalents	6.72B
Total Debt	45.06B
Net Cash	-38.34B
Net Cash Per Share	n/a
Equity (Book Value)	5.62B
Book Value Per Share	10.45
Working Capital	4.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.41 billion and capital expenditures -726.70 million, giving a free cash flow of 4.69 billion.

Operating Cash Flow	5.41B
Capital Expenditures	-726.70M
Free Cash Flow	4.69B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.59%, with operating and profit margins of 20.51% and 13.00%.

Gross Margin	60.59%
Operating Margin	20.51%
Pretax Margin	14.38%
Profit Margin	13.00%
EBITDA Margin	37.64%
EBIT Margin	20.51%
FCF Margin	19.31%

Dividends & Yields

Amgen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	3.54%
Years of Dividend Growth	5
Payout Ratio	112.70%
Buyback Yield	-0.42%
Shareholder Yield	-0.42%
Earnings Yield	2.80%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	n/a